MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state
You, S.-F.; Brase, L.; Filipello, F.; Iyer, A.; Del-Aguila, J.; He, J.; Albanus, R.; Budde, J.; Norton, J.; Gentsch, J.; Dräger, N.; Sattler, S.; Kampmann, M.; Piccio, L.; Morris, J.; Perrin, R.; McDade, E.; Dominantly Inherited Alzheimer Network, ; Paul, S.; Cashikar, A.; Benitez, B.; Harari, O.; Karch, C. M.
Show abstract
Genome-wide association studies (GWAS) have identified many modifiers of Alzheimer disease (AD) risk enriched in microglia. Two of these modifiers are common variants in the MS4A locus (rs1582763: protective and rs6591561: risk) and serve as major regulators of CSF sTREM2 levels. To understand their functional impact on AD, we used single nucleus transcriptomics to profile brains from carriers of these variants. We discovered a "chemokine" microglial subpopulation that is altered in MS4A variant carriers and for which MS4A4A is the major regulator. The protective variant increases MS4A4A expression and shifts the chemokine microglia subpopulation to an interferon state, while the risk variant suppresses MS4A4A expression and reduces this subpopulation of microglia. Our findings provide a mechanistic explanation for the AD variants in the MS4A locus. Further, they pave the way for future mechanistic studies of AD variants and potential therapeutic strategies for enhancing microglia resilience in AD pathogenesis.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 97%
- Molecular Signatures of Resilience to Alzheimer's Disease in Neocortical Layer 4 Neurons 97%
- Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy 97%
Similar papers in this journal
Similar papers in this journal
- Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease 96%
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 96%
Similar papers in this journal
- The Alzheimers Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states 98%
- Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model 96%
- A systems biology-based identification and in vivo functional screening of Alzheimer's disease risk genes reveals modulators of memory function 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.